|
End-of-day quote
Korea S.E.
14/08/2026
|
5-day change | 1st Jan Change | ||
| 2,01,000.00 KRW | -0.50% |
|
+0.85% | +16.60% |
| 04/08 | Celltrion Files Phase 3 Trial Amendment for CT-P44 Biosimilar for Myeloma | MT |
| 24/07 | Celltrion Submits EMA Marketing Authorization Application for Cosentyx Biosimilar CT-P55 | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.50% | +0.85% | +14.40% | +11.78% | +16.60% | +20.60% | +49.65% | -11.26% | +153.13% | 3.26TCr | |
| -1.78% | -1.68% | -3.23% | +19.86% | +4.61% | +1.48% | +15.31% | -22.10% | +197.67% | 4.84TCr | |
| +0.85% | -0.70% | +10.45% | +39.85% | +155.76% | +460.88% | +563.55% | +696.99% | - | 4.37TCr | |
| -2.40% | -0.23% | +11.64% | +18.48% | +14.37% | +8.13% | +71.41% | +25.81% | +1,101.11% | 3.95TCr | |
| -2.01% | -0.85% | +14.43% | +39.94% | +4.99% | +23.85% | +8.73% | -4.63% | +209.32% | 3.9TCr | |
| +0.38% | -3.23% | -7.97% | +2.77% | - | - | - | - | - | 1.63TCr | |
| -0.59% | -2.06% | +9.31% | +39.31% | +3.00% | +26.35% | +118.09% | +225.57% | +1,879.81% | 1.61TCr | |
| +0.49% | +0.92% | +1.65% | +18.83% | +12.88% | +4.11% | +23.67% | -38.08% | +86.20% | 1.42TCr | |
| -0.43% | +4.70% | +22.71% | +85.65% | +40.39% | +78.74% | +33.31% | -31.90% | +236.23% | 1.34TCr | |
| -2.59% | -0.83% | -5.19% | +40.19% | -10.47% | -7.22% | -37.03% | -31.75% | +112.21% | 1.26TCr | |
| -1.37% | +8.48% | +21.89% | +84.73% | +72.78% | +62.49% | +69.38% | -46.61% | - | 1.21TCr | |
| +0.31% | +0.15% | +1.28% | +67.19% | +23.10% | +35.07% | -14.44% | -37.98% | +159.81% | 1.13TCr | |
| -3.66% | -9.99% | -14.27% | +3.69% | -14.70% | +71.17% | +488.20% | +283.93% | +2,339.43% | 1.02TCr | |
| -0.45% | +1.68% | +15.20% | +7.07% | +24.45% | +679.12% | +2,083.39% | +77.20% | - | 1.02TCr | |
| +0.07% | -0.22% | +0.19% | +65.82% | +78.26% | +260.82% | +505.54% | - | - | 1.01TCr | |
| +2.43% | +6.33% | +14.50% | +51.79% | +77.58% | +176.62% | +726.76% | +225.23% | +1,248.70% | 1TCr | |
| +2.60% | +9.18% | +2.87% | +42.79% | +50.87% | +175.37% | +498.62% | +117.63% | - | 976.11Cr | |
| +2.45% | +1.20% | +4.59% | -22.89% | -27.65% | +30.74% | +43.10% | +44.25% | +61.47% | 951.24Cr | |
| -4.23% | -0.11% | -9.18% | +18.36% | -11.95% | -29.53% | - | - | - | 940.07Cr | |
| -0.65% | +1.54% | +4.15% | +30.23% | -9.27% | -17.32% | -12.23% | -24.76% | +34.50% | 888.21Cr | |
| Average | -0.55% | +1.78% | +5.47% | +33.27% | +26.61% | +108.50% | +290.83% | +85.15% | +601.51% | 1.89TCr | |
| Weighted average by Cap. | -0.80% | +1.21% | +6.71% | +30.99% | +32.74% | +106.33% | +218.86% | +112.53% | +532.80% |
- Stock Market
- Stocks
- A068270 Stock
- Sector Celltrion, Inc.
Select your edition
All financial news and data tailored to specific country editions
